62 related articles for article (PubMed ID: 20227514)
41. Targeting the eicosanoid pathway in hepatocellular carcinoma.
Razdan A; Main NM; Chiu V; Shackel NA; de Souza P; Bryant K; Scott KF
Am J Cancer Res; 2021; 11(6):2456-2476. PubMed ID: 34249410
[TBL] [Abstract][Full Text] [Related]
42. The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease.
Perakakis N; Stefanakis K; Mantzoros CS
Metabolism; 2020 Oct; 111S():154320. PubMed ID: 32712221
[TBL] [Abstract][Full Text] [Related]
43. Endogenous metabolites of vitamin E limit inflammation by targeting 5-lipoxygenase.
Pein H; Ville A; Pace S; Temml V; Garscha U; Raasch M; Alsabil K; Viault G; Dinh CP; Guilet D; Troisi F; Neukirch K; König S; Bilancia R; Waltenberger B; Stuppner H; Wallert M; Lorkowski S; Weinigel C; Rummler S; Birringer M; Roviezzo F; Sautebin L; Helesbeux JJ; Séraphin D; Mosig AS; Schuster D; Rossi A; Richomme P; Werz O; Koeberle A
Nat Commun; 2018 Sep; 9(1):3834. PubMed ID: 30237488
[TBL] [Abstract][Full Text] [Related]
44. Eicosanoids in metabolic syndrome.
Hardwick JP; Eckman K; Lee YK; Abdelmegeed MA; Esterle A; Chilian WM; Chiang JY; Song BJ
Adv Pharmacol; 2013; 66():157-266. PubMed ID: 23433458
[TBL] [Abstract][Full Text] [Related]
45. Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-choline-deficient diet.
Kassel KM; Guo GL; Tawfik O; Luyendyk JP
Lab Invest; 2010 Dec; 90(12):1794-804. PubMed ID: 20697377
[TBL] [Abstract][Full Text] [Related]
46. 5-lipoxygenase deficiency reduces hepatic inflammation and tumor necrosis factor alpha-induced hepatocyte damage in hyperlipidemia-prone ApoE-null mice.
Martínez-Clemente M; Ferré N; González-Périz A; López-Parra M; Horrillo R; Titos E; Morán-Salvador E; Miquel R; Arroyo V; Funk CD; Clària J
Hepatology; 2010 Mar; 51(3):817-27. PubMed ID: 20112424
[TBL] [Abstract][Full Text] [Related]
47. Melatonin protects against alcoholic liver injury by attenuating oxidative stress, inflammatory response, and apoptosis.
Hu S; Yin S; Jiang X; Huang D; Shen G
Eur J Pharmacol; 2009 Aug; 616(1-3):287-92. PubMed ID: 19576882
[TBL] [Abstract][Full Text] [Related]
48. 5-lipoxygenase activating protein signals adipose tissue inflammation and lipid dysfunction in experimental obesity.
Horrillo R; González-Périz A; Martínez-Clemente M; López-Parra M; Ferré N; Titos E; Morán-Salvador E; Deulofeu R; Arroyo V; Clària J
J Immunol; 2010 Apr; 184(7):3978-87. PubMed ID: 20207999
[TBL] [Abstract][Full Text] [Related]
49. Differential gene expression and lipid metabolism in fatty liver induced by acute ethanol treatment in mice.
Yin HQ; Kim M; Kim JH; Kong G; Kang KS; Kim HL; Yoon BI; Lee MO; Lee BH
Toxicol Appl Pharmacol; 2007 Sep; 223(3):225-33. PubMed ID: 17655900
[TBL] [Abstract][Full Text] [Related]
50. 15-lipoxygenase metabolites play an important role in the development of a T-helper type 1 allergic inflammation induced by double-stranded RNA.
Jeon SG; Moon HG; Kim YS; Choi JP; Shin TS; Hong SW; Tae YM; Kim SH; Zhu Z; Gho YS; Kim YK
Clin Exp Allergy; 2009 Jun; 39(6):908-17. PubMed ID: 19260872
[TBL] [Abstract][Full Text] [Related]
51. Protection from hepatic lipid accumulation and inflammation by genetic ablation of 5-lipoxygenase.
Titos E; Ferré N; Lozano JJ; Horrillo R; López-Parra M; Arroyo V; Clària J
Prostaglandins Other Lipid Mediat; 2010 Jun; 92(1-4):54-61. PubMed ID: 20227514
[TBL] [Abstract][Full Text] [Related]
52. Emerging Roles of 5-Lipoxygenase Phosphorylation in Inflammation and Cell Death.
Sun QY; Zhou HH; Mao XY
Oxid Med Cell Longev; 2019; 2019():2749173. PubMed ID: 31871543
[TBL] [Abstract][Full Text] [Related]
53. Lipometabolism and Glycometabolism in Liver Diseases.
Ding HR; Wang JL; Ren HZ; Shi XL
Biomed Res Int; 2018; 2018():1287127. PubMed ID: 31205932
[TBL] [Abstract][Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]